Q&A Event - Triple Negative Breast Cancer

Description

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

Crosstalk between triple negative breast cancer and microenvironment

Ask the expert: Triple-negative breast cancer with Rita Nanda, MD

Research Reveals New Avenues for Triple-Negative Breast Cancer Treatment.

Comprehensive genomic profiling validated in triple-negative breast cancer patients

Research into targeted treatments, better prediction models in breast cancer funded

What Is Triple-Negative Breast Cancer?

What's positive about 'triple-negative' breast cancer?

TNBC Day Triple Negative Breast Cancer Foundation

$ 20.50USD
Score 4.8(177)
In stock
Continue to book